"To B or Not to B"…That Is the Question: Whether We Can Identify Those at Risk for Cardiac Dysfunction During Cancer Therapy

JACC Heart Fail. 2018 Dec;6(12):1033-1034. doi: 10.1016/j.jchf.2018.09.010. Epub 2018 Nov 7.
No abstract available

Keywords: anthracycline; cardiotoxicity; heart failure stages; trastuzumab.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cardiotoxicity
  • Heart Diseases*
  • Heart Failure*
  • Humans
  • Neoplasms*